BG Medicine names new EVP and general manager of diagnostics

In this newly created role, Mr White will be responsible for the strategic direction and overall management of the company’s commercial operations as it advances a broad portfolio of high-value diagnostic tests toward commercial launch, said BG Medicine.

Prior to joining BG Medicine, Mr White served as Qiagen’s senior vice president of sales and marketing for the Americas, and chair of the Americas Management Council, where among other responsibilities he played a critical role in the integration of Digene following its acquisition.

Pieter Muntendam, president and CEO of BG Medicine, said: “Doug’s vast experience with leading diagnostics innovators will be a tremendous asset to BG Medicine as we prepare to commercialize important new diagnostics in cardiology and other therapeutic areas. The success that Doug achieved in a variety of commercial leadership roles has prepared him well to help BG Medicine effectively develop and penetrate these large, important markets.”